Omics integration for precision cancer immunotherapy

Project Information

IMMUNOMARK

Grant agreement ID: 799818

DOI 10.3030/799818

Project closed

EC signature date 19 February 2018

Start date 1 March 2018

End date 29 February 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 170 121,60

EU contribution € 170 121,60

Coordinated by

FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Spain

Publications

Peer reviewed articles (2)

Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response

Author(s): Qingyang Xiao, André Nobre, Pilar Piñeiro, Miguel-Ángel Berciano-Guerrero, Emilio Alba, Manuel Cobo, Volker M. Lauschke, Isabel Barragán
Published in: Journal of Clinical Medicine, Issue 9/1, 2020, Page(s) 286, ISSN 2077-0383
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/jcm9010286

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

Author(s): Michäel Duruisseaux, Anna Martínez-Cardús, Maria E Calleja-Cervantes, Sebastian Moran, Manuel Castro de Moura, Veronica Davalos, David Piñeyro, Montse Sanchez-Cespedes, Nicolas Girard, Marie Brevet, Etienne Giroux-Leprieur, Coraline Dumenil, Monica Pradotto, Paolo Bironzo, Enrica Capelletto, Silvia Novello, Alexis Cortot, Marie-Christine Copin, Niki Karachaliou, Maria Gonzalez-Cao, Sergio Pera
Published in: The Lancet Respiratory Medicine, Issue 6/10, 2018, Page(s) 771-781, ISSN 2213-2600
Publisher: Elsevier Limited
DOI: 10.1016/s2213-2600(18)30284-4